Design, Synthesis, and Structure–Activity Relationships of Highly Potent 5-HT3 Receptor Ligands
Author(s) -
Mark H.P. Verheij,
Andrew J. Thompson,
Jacqueline E. van MuijlwijkKoezen,
Sarah C. R. Lummis,
Rob Leurs,
Iwan J. P. de Esch
Publication year - 2012
Publication title -
journal of medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.01
H-Index - 261
eISSN - 1520-4804
pISSN - 0022-2623
DOI - 10.1021/jm300801u
Subject(s) - pharmacophore , chemistry , quinazoline , stereochemistry , docking (animal) , receptor , structure–activity relationship , quinoline , molecular model , ligand (biochemistry) , in silico , homology modeling , amine gas treating , combinatorial chemistry , in vitro , biochemistry , enzyme , medicine , nursing , organic chemistry , gene
The 5-HT₃ receptor, a pentameric ligand-gated ion channel (pLGIC), is an important therapeutic target. During a recent fragment screen, 6-chloro-N-methyl-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine (1) was identified as a 5-HT₃ hit fragment. Here we describe the synthesis and structure-activity relationships (SAR) of a series of (iso)quinoline and quinazoline compounds that were synthesized and screened for 5-HT₃ R affinity using a [³H]granisetron displacement assay. These studies resulted in the discovery of several high affinity ligands of which compound 22 showed the highest affinity (pK(i) > 10) for the 5-HT₃ receptor. The observed SAR is in agreement with established pharmacophore models for 5-HT₃ ligands and is used for ligand-receptor binding mode prediction using homology modeling and in silico docking approaches.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom